Monday, November 30, 2020

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug The tentatively approved product is the generic version of Inlyta tablets of PF Prism CV.

from Moneycontrol Business News https://ift.tt/33u15rC

No comments:

Post a Comment

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...